Remote Patient Monitoring (RPM) is continuing to gain momentum as more people seek to manage chronic medical conditions from the comfort of their own home. Healthcare professionals are sighting not only an emphasis on a greater quality of life for patients with reduced time in-hospital and fewer reoccurring appointments with the capabilities of remote patient monitoring devices but also a reduction in cost and efficiencies as propellants for the uptake in adoption.
According to a recent article by Business Wire, North America is the largest region to adopt RPM technology and is expected to remain the largest for the next five years. With more than 133 million Americans having at lease one chronic disease and being at risk for rehospitalization the investment in RPM is helping to transition to value-based care and invigorating healthcare device manufacturers to take a new look at remote patient monitoring devices.
BioIntelliSense, a KORE customer, has recently brought to market the first FDA-cleared single-use device for up to 30 days of continuous vital sign monitoring. KORE is proud to provide secure and continuous connectivity to these devices as well as certification services to speed time to market.
“KORE was frankly a God-send. In the first place they solved engineering challenges which would have taken us upwards to a year to solve on our own.”
James Mault, MD, FACS, Founder & CEO